RNF40 has been reported as a tumor suppressor in colorectal cancer (CRC), but has also been reported as an oncogene in other cancers, including prostate and liver cancers, and MLL-rearranged acute lymphoblastic leukemia (ALL). Here, RNF40 is linked to colorectal carcinoma.